Abstract
Purpose
The aim of the present study is to identify predictive imaging findings and construct a diagnostic model for differentiating renal cell carcinoma (RCC) with and without sarcomatoid dedifferentiation (sRCC and non-sRCC).
Methods
This study is a single-center retrospective study. All patients had magnetic resonance imaging (MRI) with gradient-echo T1-weighted images, single-shot T2-weighted images (T2WI), and enhanced nephrographic phase images. Forty pathologically confirmed sRCCs and 80 non-sRCCs were included in this study. Control cases were selected by matching the tumor diameter and the year of MRI. Two radiologists independently evaluated the following findings: growth pattern, presence of low-intensity area on T2WI in the tumor (T2LIA), presence of non-enhancing area, local tumor stage, and presence of regional lymphadenopathy. Two radiologists measured the diameter of the tumor, T2LIA, and the non-enhancing area. Multivariable logistic regression analysis was used to identify independent predictive factors for differentiating sRCC from non-sRCC. Selected variables were entered in the logistic regression model, and the area under the curve (AUC) was calculated for each reader with 95% confidence intervals (CIs).
Results
Larger T2LIA-to-tumor diameter ratio, regional lymphadenopathy, and local tumor stage 4 were associated with sRCC, and selected for the subsequent construction of a logistic regression model. With this model, the AUCs were 0.76 (95% CI, 0.66–0.85) and 0.70 (95% CI, 0.59–0.81) for prediction of sRCC.
Conclusion
In conclusion, larger T2LIA-to-tumor diameter ratio, regional lymphadenopathy, and local tumor stage 4 are predictive findings of sRCC. As a result, the model constructed using these findings demonstrated a moderate degree of diagnostic accuracy.
Similar content being viewed by others
References
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 25(3):275-284.
Tomera KM, Farrow GM, Lieber MM (1983) Sarcomatoid renal carcinoma. J Urol. 130(4):657-659.
Sella A, Logothetis CJ, Ro JY, Swanson DA, Samuels ML (1987) Sarcomatoid renal cell carcinoma. A treatable entity. Cancer. 60(6):1313-1318.
Lebacle C, Pooli A, Bessede T, Irani J, Pantuck AJ, Drakaki A (2019) Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J Urol. 37(1):115-123. https://doi.org/https://doi.org/10.1007/s00345-018-2355-y
Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML (2011) Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol. 59(1):18-23. https://doi.org/https://doi.org/10.1016/j.eururo.2010.08.042
Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL (2002) Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 167(1):65-70.
Shuch B, Said J, La Rochelle JC, Zhou Y, Li G, Klatte T, Kabbinaavar FF, Pantuck AJ, Belldegrun AS (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable? J Urol. 182(5):2164-2171. https://doi.org/https://doi.org/10.1016/j.juro.2009.07.049
Shuch B, Bratslavsky G, Linehan WM, Srinivasan R (2012) Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist. 17(1):46-54. https://doi.org/https://doi.org/10.1634/theoncologist.2011-0227
Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ (2019) Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet. 393(10189):2404-2415. https://doi.org/https://doi.org/10.1016/s0140-6736(19)30723-8
Rosenkrantz AB, Chandarana H, Melamed J (2011) MRI findings of sarcomatoid renal cell carcinoma in nine cases. Clin Imaging. 35(6):459-464. https://doi.org/https://doi.org/10.1016/j.clinimag.2010.11.002
Takeuchi M, Urano M, Hara M, Fujiyoshi Y, Inagaki H, Shibamoto Y (2013) Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation. Clin Imaging. 37(5):908-912. https://doi.org/https://doi.org/10.1016/j.clinimag.2013.04.010
Young JR, Young JA, Margolis DJA, Sauk S, Sayre J, Pantuck AJ, Raman SS (2017) Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. Acad Radiol. 24(10):1226-1232. https://doi.org/https://doi.org/10.1016/j.acra.2017.03.017
Takeuchi M, Kawai T, Suzuki T, Naiki T, Kawai N, Fujiyoshi Y, Inagaki H, Kohri K, Hara M, Shibamoto Y (2015) MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types. Abdom Imaging. 40(1):112-119. https://doi.org/https://doi.org/10.1007/s00261-014-0185-y
Meng X, Shu J, Xia Y, Yang R (2020) A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma. Biomed Res Int. 2020:7103647. https://doi.org/https://doi.org/10.1155/2020/7103647
Mazin A, Hawkins SH, Stringfield O, Dhillon J, Manley BJ, Jeong DK, Raghunand N (2021) Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI. Sci Rep. 11(1):3785. https://doi.org/https://doi.org/10.1038/s41598-021-83271-4
Gurbani S, Morgan D, Jog V, Dreyfuss L, Shen M, Das A, Abel EJ, Lubner MG (2021) Evaluation of radiomics and machine learning in identification of aggressive tumor features in renal cell carcinoma (RCC). Abdom Radiol (NY). 46(9):4278-4288. https://doi.org/https://doi.org/10.1007/s00261-021-03083-y
Pickhardt PJ, Lonergan GJ, Davis CJ, Jr., Kashitani N, Wagner BJ (2000) From the archives of the AFIP. Infiltrative renal lesions: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics. 20(1):215-243. https://doi.org/https://doi.org/10.1148/radiographics.20.1.g00ja08215
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17(6):1471-1474. https://doi.org/https://doi.org/10.1245/s10434-010-0985-4
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. 33(1):159-174.
Zou H, Hastie T (2005) Regularization and Variable Selection via the Elastic Net. Journal of the Royal Statistical Society Series B (Statistical Methodology). 67(2):301-320.
Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012) Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 109(11):1600-1606. https://doi.org/https://doi.org/10.1111/j.1464-410X.2011.10785.x
Keskin SK, Msaouel P, Hess KR, Yu KJ, Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA, Tannir NM (2017) Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras. J Urol. 198(3):530-537. https://doi.org/https://doi.org/10.1016/j.juro.2017.04.067
Gurbani S, Morgan D, Jog V, Dreyfuss L, Shen M, Das A, Abel EJ, Lubner MG (2021) Evaluation of radiomics and machine learning in identification of aggressive tumor features in renal cell carcinoma (RCC). Abdom Radiol (NY). https://doi.org/https://doi.org/10.1007/s00261-021-03083-y
Jeong D, Raghunand N, Hernando D, Poch M, Jeong K, Eck B, Dhillon J (2018) Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging. Quant Imaging Med Surg. 8(4):373-382. https://doi.org/https://doi.org/10.21037/qims.2018.04.09
Funding
This study was not funded from any grants or sources.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Takeuchi, M., Froemming, A.T., Kawashima, A. et al. Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation. Abdom Radiol 47, 2168–2177 (2022). https://doi.org/10.1007/s00261-022-03501-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03501-9